Shanghai Pharmaceuticals Holding Co., Ltd (FRA:S1R)

Market Cap	7.19B -3.5%
Revenue (ttm)	37.30B +4.3%
Net Income	614.67M -21.4%
EPS	0.17 -21.4%
Shares Out	n/a
PE Ratio	7.09
Forward PE	9.33
Dividend	0.07 (5.94%)
Ex-Dividend Date	Sep 16, 2026

Volume	n/a
Open	1.230
Previous Close	1.210
Day's Range	1.220 - 1.230
52-Week Range	1.160 - 1.370
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About FRA:S1R

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as in...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1994
• Employees: 48,640
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: S1R

Financial Performance

In 2025, FRA:S1R's revenue was 283.58 billion, an increase of 3.03% compared to the previous year's 275.25 billion. Earnings were 5.72 billion, an increase of 25.74%.

Financial numbers in CNY

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 24, 2026

Data Sources Report a data error